Innes

EQS-News: Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer

Retrieved on: 
Sunday, January 22, 2023

New York, NY, January 5, 2023 - Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health indications related to life-altering diseases, today announces that Innes Meldrum has been appointed President and Chief Executive Officer.

Key Points: 
  • New York, NY, January 5, 2023 - Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health indications related to life-altering diseases, today announces that Innes Meldrum has been appointed President and Chief Executive Officer.
  • Innes Meldrum has nearly 30 years of global experience in the biotechnology and technology industries, having most recently served as Senior Vice President and Chief Commercial Officer for Otsuka Pharmaceuticals North America.
  • “We are delighted to have Innes join Reset Pharma as CEO,” said Philip Taub, Chair of the Board.
  • I warmly welcome Innes and look forward to working with him and the entire Reset Pharma team.

Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer

Retrieved on: 
Thursday, January 5, 2023

NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health indications related to life-altering diseases, today announces that Innes Meldrum has been appointed President and Chief Executive Officer.

Key Points: 
  • NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health indications related to life-altering diseases, today announces that Innes Meldrum has been appointed President and Chief Executive Officer.
  • Innes Meldrum has nearly 30 years of global experience in the biotechnology and technology industries, having most recently served as Senior Vice President and Chief Commercial Officer for Otsuka Pharmaceuticals North America.
  • “We are delighted to have Innes join Reset Pharma as CEO,” said Philip Taub, Chair of the Board.
  • I warmly welcome Innes and look forward to working with him and the entire Reset Pharma team.

Cambridge Savings Bank Supports the Redevelopment and Expansion of the Innes Apartments as Lead Bank in $93 Million Construction Loan

Retrieved on: 
Thursday, December 8, 2022

Cambridge Savings Bank (CSB), a full-service mutual bank with a customer-first approach and $6 billion in assets, today announced it is the lead bank in a $93 million construction loan to support the Innes Redevelopment Project, with the development of two new multi-purpose buildings in Chelsea, MA.

Key Points: 
  • Cambridge Savings Bank (CSB), a full-service mutual bank with a customer-first approach and $6 billion in assets, today announced it is the lead bank in a $93 million construction loan to support the Innes Redevelopment Project, with the development of two new multi-purpose buildings in Chelsea, MA.
  • The mixed-income redevelopment will also include onsite amenities for residents and much needed ground-floor retail space to activate the Central Avenue Smart Growth area.
  • It has been a long journey to get to this point in the process and our partners at Cambridge Savings Bank have played a huge role in making it all possible.
  • Marcus Partners and its affiliates own, operate and are developing 6M+ square feet of real estate and 1,500+ multifamily units.

Sound Royalties CEO Alex Heiche Joins Music Copyrights Panel at North American Law Summit as Key Panelist

Retrieved on: 
Wednesday, November 10, 2021

WEST PALM BEACH, Fla., Nov. 10, 2021 /PRNewswire-PRWeb/ --On Friday, November 12, 2021, Sound Royalties CEO Alex Heiche will take part in a panel at the 33rd annual North American Law Summit.

Key Points: 
  • WEST PALM BEACH, Fla., Nov. 10, 2021 /PRNewswire-PRWeb/ --On Friday, November 12, 2021, Sound Royalties CEO Alex Heiche will take part in a panel at the 33rd annual North American Law Summit.
  • Each year, the North American Law Summit delivers a continuing legal education conference, focused on constantly-evolving topics within entertainment, sports, media, and IP.
  • "Music royalties and catalog sales are an intricate and often misunderstood sector of the music industry," said Heiche.
  • "We are proud to be selected to participate in the North American Law Summit this year to continue sharing awareness and data-backed insights with the legal community.

Celebrating 1 Million Games Sold, Anomia Press Launches New Website

Retrieved on: 
Monday, August 16, 2021

To celebrate the 1 million milestone, Andrew Innes, Inventor and Anomia Press owner, is launching a very special website.

Key Points: 
  • To celebrate the 1 million milestone, Andrew Innes, Inventor and Anomia Press owner, is launching a very special website.
  • In the future, the new site will also be home to custom Anomia games, Anomia print and play, lesson plans for educators and more!
  • Visit Anomia Press to see the new look and sign up for Anomia fun and start hearing about all things Anomia!
  • To date, over 1 million Anomia games have been sold and the company now markets a whole line of games - Anomia Party, Anomia (original), Anomia X, Anomia Kids and Duple.

John Innes Centre Continues Retrofit With New Order of Heliospectra Intelligent Lighting Solutions

Retrieved on: 
Monday, November 19, 2018

GOTHENBURG, SwedenandSAN FRANCISCO, Nov. 19, 2018 /PRNewswire/ -- Heliospectra AB (publ) (OTCQB: HLSPY) (FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from the prestigious John Innes Centre in the UK.

Key Points: 
  • GOTHENBURG, SwedenandSAN FRANCISCO, Nov. 19, 2018 /PRNewswire/ -- Heliospectra AB (publ) (OTCQB: HLSPY) (FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from the prestigious John Innes Centre in the UK.
  • Furthermore, LED lighting is a sustainable option that has helped us reduce energy consumption to save money, reduce pollution and minimize environmental footprint, said Dr. Brande Wulff, Project Leader Crop Genetics at the John Innes Centre.
  • "As one of Europe's leading research institutions, the John Innes Centre is pushing the boundaries of plant science.
  • Control, intense light, and a reliable light solution are of highest importance," said Ali Ahmadian, CEO Heliospectra AB.